Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App





Certest Present Latest Innovations in Diagnosis of Infectious Diseases

By LabMedica International staff writers
Posted on 22 Jul 2023

CerTest Biotec (Zaragoza, Spain), a company specializing in the development, manufacturing, and commercialization of solutions for the diagnosis of infectious diseases, is participating in AACC 2023. More...

Recognized as one of the largest global gatherings for the diagnostics sector, the annual AACC exhibition offers attendees the opportunity to explore the latest trends, technologies, and advances in the field of clinical diagnostics. With the participation of over 800 exhibitors, numerous experts, and industry leaders, this exhibition has established itself as a key meeting point for networking, knowledge exchange, and discovering the latest innovations in the sector.

Certest is taking advantage of this important platform to present its latest innovations in the diagnosis of infectious diseases, with a clear focus on the flexibility of its products and processes, as well as the speed and accuracy of results. Certest is showcasing a wide range of solutions, including rapid tests, RT-PCR tests (based on molecular biology), chemiluminescence (CLIA), and turbidimetry, in addition to raw materials for diagnostic product manufacturers.

One of the highlights of Certest’s participation in the exhibition is the demonstration of the VIASURE Complete System. This integrated system offers a comprehensive solution for the diagnosis of infectious diseases, providing fast and reliable results that improve workflow in the diagnostic laboratory. Thanks to its advanced technology, VIASURE solutions deliver exceptional performance and increased efficiency in diagnostic laboratories. In addition to product and solution showcases, Certest is also involved in research, presenting up to 14 publications in the form of posters, reflecting the latest studies conducted by the company, mainly in the field of molecular biology.

Related Links:
CerTest Biotec 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.